Should Value Investors Buy Dun & Bradstreet (DNB) Stock?

Zacks research identifies Dun & Bradstreet (DNB) as a compelling value investment, assigning it a Zacks Rank #2 (Buy) and an 'A' grade for Value. The analysis highlights DNB's favorable valuation metrics, including a PEG ratio of 1.87 compared to the industry average of 2.52, and a P/S ratio of 1.69 versus the industry average of 4. These figures suggest DNB is currently undervalued and presents as an impressive value stock.

Analysis

Dun & Bradstreet (DNB) has been identified as a compelling value opportunity, supported by a Zacks Rank #2 (Buy) and a top-tier 'A' grade for Value. The company's valuation appears attractive relative to its peers, a conclusion substantiated by key financial metrics. DNB's Price-to-Earnings-Growth (PEG) ratio is 1.87, which is significantly below the industry average of 2.52 and also under its own 12-month median of 2.01, indicating a potentially discounted valuation relative to both its industry and its recent history. Furthermore, the value case is strengthened by its Price-to-Sales (P/S) ratio of 1.69, which represents a substantial discount when compared against the industry average of 4. The combination of these favorable valuation metrics with a positive earnings outlook, as implied by its Zacks rank, underpins the thesis that DNB is currently an undervalued stock.

Key Decisions for Investors

• Value-oriented investors may find DNB an attractive candidate for accumulation, given its 'A' grade for Value and its significant discount on both PEG and P/S ratios relative to industry benchmarks.
• The stock's current valuation, with a PEG ratio of 1.87 sitting below its one-year median of 2.01, could represent a favorable entry point for initiating or adding to a position.
• Investors should monitor upcoming earnings announcements and analyst estimate revisions, as the bullish thesis is heavily dependent on the company's ability to deliver the growth implied by its favorable Zacks Rank.